Electromyogram Biofeedback in Patients with Fibromyalgia: A Randomized Controlled Trial
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Background/Aim: Electromyogram (EMG) biofeedback is used in chronic pain but its effectiveness in patients with fibromyalgia is unclear. The objective of this randomized controlled clinical trial was to evaluate the effectiveness of EMG biofeedback in patients with fibromyalgia. Methods: Patients were recruited from a waiting list at the fibromyalgia day care clinic at the University Hospital Munich. The study intervention comprised 14 sessions of EMG biofeedback during 8 weeks in addition to the usual care. The control intervention was usual care alone. Assessments were scheduled before intervention (T0), after intervention (T1), and 3 months after the end of intervention (T2). The primary outcome measure was the Fibromyalgia Impact Questionnaire (FIQ). Secondary outcome measures included additional patient-oriented measures and the pressure-pain threshold in the trapezius muscles. Effectiveness was analyzed by significance tests and standardized effect sizes (ES). Results: 36 patients completed the study. EMG biofeedback did not improve the health status (FIQ, T1: p = 0.95, ES = 0.02; T2: p = 0.52, ES = 0.26). Among the secondary outcome measures, only the pressure-pain threshold at the trapezius muscles showed an improvement in the intervention group (T1: p = 0.016, ES = 0.84). Conclusion: EMG biofeedback showed no health status improvement in patients with fibromyalgia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Trapezius exercises guided by electromyogram biofeedback were effective for the increase of local PPT in the short term [60].”
From Effectiveness of non-pharmacological conservative therapies in adults with fibromyalgia: A systematic review of high-quality clinical trials (2022) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
(1992) · PubMed · Cited by 33,716
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
SCL-90: an outpatient psychiatric rating scale--preliminary report.
Derogatis, L. R., Lipman, R. S., & Covi, L. (1973) · PubMed · Cited by 3,800
Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
Ware, J. E., & Gandek, B. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00081-x · Cited by 2,605
(1991) · PubMed · Cited by 1,837
Sangha, O., Stucki, G., Liang, M. H., Fossel, A. H., & Katz, J. N. (2003) · Arthritis Care & Research · doi:10.1002/art.10993 · Cited by 1,806
Fischer, A. A. (1987) · Pain · doi:10.1016/0304-3959(87)90089-3 · Cited by 958
Bullinger, M. (1995) · Social Science & Medicine · doi:10.1016/0277-9536(95)00115-n · Cited by 763
Bennett, R. M. (2005) · PubMed · Cited by 726
Research works printed but not linked: 102
- Aaron, L. A., M. M. Burke, et al. (2000). "Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder." Arch Intern Med 160 (2): 221-7.
- Adams, N. and J. Sim (2005). "Rehabilitation approaches in fibromyalgia." Disabil Rehabil 27 (12): 711-23.
- Arnold, B., W. Hauser, et al. (2008). "[Multicomponent therapy for treatment of fibromyalgia syndrome]." Schmerz 22 (3): 334-8.
- Arnold, L. M. (2006). "Biology and therapy of fibromyalgia. New therapies in fibromyalgia." Arthritis Res Ther 8 (4): 212.
- Arnold, L. M., D. L. Goldenberg, et al. (2007). "Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial." Arthritis Rheum 56 (4): 1336-44.
- Arnold, L. M., E. V. Hess, et al. (2002). "A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia." Am J Med 112 (3): 191-7.
- Arnold, L. M., P. E. Keck, Jr., et al. (2000). "Antidepressant treatment of fibromyalgia. A meta-analysis and review." Psychosomatics 41 (2): 104-13.
- Arnold, L. M., Y. Lu, et al. (2004). "A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder." Arthritis Rheum 50 (9): 2974-84.
- Astin, J. A., B. M. Berman, et al. (2003). "The efficacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: a randomized controlled trial." J Rheumatol 30 (10): 2257-62.
- Barkhudaryan, N. and A. J. Dunn (1999). "Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitaryadrenocortical axis." Neurochem Res 24 (9): 1169-80.
- Bazzichi, L., G. Giannaccini, et al. (2006). "Alteration of serotonin transporter density and activity in fibromyalgia." Arthritis Res Ther 8 (4): R99.
- Bendtsen, L., J. Norregaard, et al. (1997). "Evidence of qualitatively altered nociception in patients with fibromyalgia." Arthritis Rheum 40 (1): 98-102.
- Bennett, R. M., M. Kamin, et al. (2003). "Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study." Am J Med 114 (7): 537-45.
- Bennett, R. M., J. Schein, et al. (2005). "Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen." Arthritis Rheum 53 (4): 519-27.
- Biasi, G., S. Manca, et al. (1998). "Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo." Int J Clin Pharmacol Res 18 (1): 13-9.
- Bradley, L. A., N. L. McKendree-Smith, et al. (2000). "Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia." Curr Rheumatol Rep 2 (2): 141-8.
- Buckelew, S. P., R. Conway, et al. (1998). "Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial." Arthritis Care Res 11 (3): 196-209.
- Burckhardt, C. S. (2006). "Multidisciplinary approaches for management of fibromyalgia." Curr Pharm Des 12 (1): 59-66.
- Burgmer, M., E. Pogatzki-Zahn, et al. (2009). "Altered brain activity during pain processing in fibromyalgia." Neuroimage 44 (2): 502-8.
- Clauw, D. J. and L. J. Crofford (2003). "Chronic widespread pain and fibromyalgia: what we know, and what we need to know." Best Pract Res Clin Rheumatol 17 (4): 685-701.
- Conrad, I. (2003). "[Diagnosis and clinical signs of fibromyalgia]." Schmerz 17 (6): 464-74.
- Crofford, L. J., S. R. Pillemer, et al. (1994). "Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia." Arthritis Rheum 37 (11): 1583-92.
- Crofford, L. J., M. C. Rowbotham, et al. (2005). "Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial." Arthritis Rheum 52 (4): 1264-73.
- Crofford, L. J., E. A. Young, et al. (2004). "Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome." Brain Behav Immun 18 (4): 314-25.
- Dadabhoy, D. and D. J. Clauw (2006). "Therapy Insight: fibromyalgia--a different type of pain needing a different type of treatment." Nat Clin Pract Rheumatol 2 (7): 364-72.
- Drexler, A. R., E. J. Mur, et al. (2002). "Efficacy of an EMG-biofeedback therapy in fibromyalgia patients. A comparative study of patients with and without abnormality in (MMPI) psychological scales." Clin Exp Rheumatol 20 (5): 677-82.
- Edwards, R. R., C. O. Bingham, 3rd, et al. (2006). "Catastrophizing and pain in arthritis, fibromyalgia, and other rheumatic diseases." Arthritis Rheum 55 (2): 325-32.
- Egle, U. T. and B. van Houdenhove (2006). "[Fibromyalgia: a stress induced pain illness?]." Schmerz 20 (2): 99-100.
- Eich, W., W. Hauser, et al. (2008). "[Definition, classification and diagnosis of fibromyalgia syndrome]." Schmerz 22 (3): 255-66.
- Epstein, S. A., G. Kay, et al. (1999). "Psychiatric disorders in patients with fibromyalgia. A multicenter investigation." Psychosomatics 40 (1): 57-63.
- Ferraccioli, G., L. Ghirelli, et al. (1987). "EMG-biofeedback training in fibromyalgia syndrome." J Rheumatol 14 (4): 820-5.
- Finset, A., S. H. Wigers, et al. (2004). "Depressed mood impedes pain treatment response in patients with fibromyalgia." J Rheumatol 31 (5): 976-80.
- Fishbain, D. A., R. Cutler, et al. (1997). "Chronic pain-associated depression: antecedent or consequence of chronic pain? A review." Clin J Pain 13 (2): 116-37.
- Forseth, K. K. and J. T. Gran (2002). "Management of fibromyalgia: what are the best treatment choices?" Drugs 62 (4): 577-92.
- Gard, G. (2005). "Body awareness therapy for patients with fibromyalgia and chronic pain." Disabil Rehabil 27 (12): 725-8.
- Gendreau, R. M., M. D. Thorn, et al. (2005). "Efficacy of milnacipran in patients with fibromyalgia." J Rheumatol 32 (10): 1975-85.
- Giesecke, T., D. A. Williams, et al. (2003). "Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors." Arthritis Rheum 48 (10): 2916-22.
- Goldenberg, D. L., C. Burckhardt, et al. (2004). "Management of fibromyalgia syndrome." Jama 292 (19): 2388-95.
- Gracely, R. H., M. A. Grant, et al. (2003). "Evoked pain measures in fibromyalgia." Best Pract Res Clin Rheumatol 17 (4): 593-609.
- Gracely, R. H., F. Petzke, et al. (2002). "Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia." Arthritis Rheum 46 (5): 1333-43.
- Gronemann, S. T., S. Ribel-Madsen, et al. (2004). "Collagen and muscle pathology in fibromyalgia patients." Rheumatology (Oxford) 43 (1): 27-31.
- Guedj, E., S. Cammilleri, et al. (2008). "Clinical correlate of brain SPECT perfusion abnormalities in fibromyalgia." J Nucl Med 49 (11): 1798-803.
- Gupta, A. and A. J. Silman (2004). "Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link." Arthritis Res Ther 6 (3): 98-106.
- Hammond, A. and K. Freeman (2006). "Community patient education and exercise for people with fibromyalgia: a parallel group randomized controlled trial." Clin Rehabil 20 (10): 835-46.
- Harden, R. N., G. Revivo, et al. (2007). "A critical analysis of the tender points in fibromyalgia." Pain Med 8 (2): 147-56.
- Hassett, A. L., J. D. Cone, et al. (2000). "The role of catastrophizing in the pain and depression of women with fibromyalgia syndrome." Arthritis Rheum 43 (11): 2493500.
- Hassett, A. L., D. C. Radvanski, et al. (2007). "A pilot study of the efficacy of heart rate variability (HRV) biofeedback in patients with fibromyalgia." Appl Psychophysiol Biofeedback 32 (1): 1-10.
- Hauser, W. (2005). "[Fibromyalgia in the legal procedures of the german sozialgericht -psychosocial risk factors and predictors of health care utilization]." Psychother Psychosom Med Psychol 55 (2): 72-8.
- Hauser, W., C. Zimmer, et al. (2008). "[What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association]." Schmerz 22 (2): 176-83.
- Holman, A. J. and R. R. Myers (2005). "A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications." Arthritis Rheum 52 (8): 2495-505.
- Hwang, E. and A. Barkhuizen (2006). "Update on rheumatologic mimics of fibromyalgia." Curr Pain Headache Rep 10 (5): 327-32.
- Igl, W., C. Zwingmann, et al. (2006). "[Sensitivity to change of questionnaires measuring subjective health--results of a prospective comparative study]." Rehabilitation (Stuttg) 45 (4): 232-42.
- Imbierowicz, K. and U. T. Egle (2003). "Childhood adversities in patients with fibromyalgia and somatoform pain disorder." Eur J Pain 7 (2): 113-9.
- Inanici, F. and M. B. Yunus (2004). "History of fibromyalgia: past to present." Curr Pain Headache Rep 8 (5): 369-78.
- Jacobs, J. W., J. J. Rasker, et al. (1996). "Lack of correlation between the mean tender point score and self-reported pain in fibromyalgia." Arthritis Care Res 9 (2): 105-11.
- Jacobsen, S., E. M. Bartels, et al. (1991). "Single cell morphology of muscle in patients with chronic muscle pain." Scand J Rheumatol 20 (5): 336-43.
- JAMA (1996). "Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. NIH Technology Assessment Panel on Integration of Behavioral and Relaxation Approaches into the Treatment of Chronic Pain and Insomnia." Jama 276 (4): 313-8.
- Jones, K. D., P. Deodhar, et al. (2007). "Growth hormone perturbations in fibromyalgia: a review." Semin Arthritis Rheum 36 (6): 357-79.
- Kashikar-Zuck, S., N. F. Swain, et al. (2005). "Efficacy of cognitive-behavioral intervention for juvenile primary fibromyalgia syndrome." J Rheumatol 32 (8): 1594-602.
- Kim, S. H. (2007). "Skin biopsy findings: implications for the pathophysiology of fibromyalgia." Med Hypotheses 69 (1): 141-4.
- Klement, A., W. Hauser, et al. (2008). "[Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain]." Schmerz 22 (3): 283-94.
- Krell, H. V., A. F. Leuchter, et al. (2005). "Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain." Psychosomatics 46 (5): 379-84.
- Kuchinad, A., P. Schweinhardt, et al. (2007). "Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain?" J Neurosci 27 (15): 4004-7.
- Langhorst, J., W. Hauser, et al. (2008). "[Alternative and complementary therapies in fibromyalgia syndrome]." Schmerz 22 (3): 324-33.
- Lawson, K. (2006). "Emerging pharmacological therapies for fibromyalgia." Curr Opin Investig Drugs 7 (7): 631-6.
- Littlejohn, G. O. and E. K. Guymer (2006). "Fibromyalgia syndrome: which antidepressant drug should we choose." Curr Pharm Des 12 (1): 3-9.
- Lund, N., A. Bengtsson, et al. (1986). "Muscle tissue oxygen pressure in primary fibromyalgia." Scand J Rheumatol 15 (2): 165-73.
- Lyseng-Williamson, K. A. and M. A. Siddiqui (2008). "Pregabalin: a review of its use in fibromyalgia." Drugs 68 (15): 2205-23.
- Mannerkorpi, K. and M. D. Iversen (2003). "Physical exercise in fibromyalgia and related syndromes." Best Pract Res Clin Rheumatol 17 (4): 629-47.
- McBeth, J., G. J. Macfarlane, et al. (1999). "The association between tender points, psychological distress, and adverse childhood experiences: a community-based study." Arthritis Rheum 42 (7): 1397-404.
- Mease, P. (2005). "Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment." J Rheumatol Suppl 75 : 6-21.
- Mease, P., L. M. Arnold, et al. (2007). "Fibromyalgia syndrome." J Rheumatol 34 (6): 1415-25.
- Moldofsky, H., F. A. Lue, et al. (1996). "The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study." J Rheumatol 23 (3): 529-33.
- Muller, W. and J. Lautenschlager (1990). "[Generalized tendomyopathy. I: Clinical aspects, follow-up and differential diagnosis]." Z Rheumatol 49 (1): 11-21.
- Muller, W. and J. Lautenschlager (1990). "[Generalized tendomyopathy. II: Pathogenesis and therapy]." Z Rheumatol 49 (1): 22-9.
- Muller, W., E. M. Schneider, et al. (2007). "The classification of fibromyalgia syndrome." Rheumatol Int 27 (11): 1005-10.
- Nishishinya, B., G. Urrutia, et al. (2008). "Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy." Rheumatology (Oxford) 47 (12): 1741-6.
- Panton, L. B., J. D. Kingsley, et al. (2006). "A comparison of physical functional performance and strength in women with fibromyalgia, age- and weight-matched controls, and older women who are healthy." Phys Ther 86 (11): 1479-88.
- Petzke, F., D. J. Clauw, et al. (2003). "Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation." Pain 105 (3): 403-13.
- Petzke, F., R. H. Gracely, et al. (2003). "What do tender points measure? Influence of distress on 4 measures of tenderness." J Rheumatol 30 (3): 567-74.
- Pioro-Boisset, M., J. M. Esdaile, et al. (1996). "Alternative medicine use in fibromyalgia syndrome." Arthritis Care Res 9 (1): 13-7.
- Raphael, K. G., M. N. Janal, et al. (2004). "Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women." Pain Med 5 (1): 33-41.
- Raphael, K. G., M. N. Janal, et al. (2004). "Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses." Pain 110 (1-2): 449-60.
- Redondo, J. R., C. M. Justo, et al. (2004). "Long-term efficacy of therapy in patients with fibromyalgia: a physical exercise-based program and a cognitive-behavioral approach." Arthritis Rheum 51 (2): 184-92.
- Russell, I. J., M. D. Orr, et al. (1994). "Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome." Arthritis Rheum 37 (11): 1593-601.
- Russell, I. J., H. Vaeroy, et al. (1992). "Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis." Arthritis Rheum 35 (5): 550-6.
- Sayar, K., G. Aksu, et al. (2003). "Venlafaxine treatment of fibromyalgia." Ann Pharmacother 37 (11): 1561-5.
- Schwarz, M. J., M. Offenbaecher, et al. (2002). "Evidence for an altered tryptophan metabolism in fibromyalgia." Neurobiol Dis 11 (3): 434-42.
- Sommer, C., W. Hauser, et al. (2008). "[Pharmacological treatment of fibromyalgia syndrome]." Schmerz 22 (3): 313-23.
- Sprott, H. (2003). "What can rehabilitation interventions achieve in patients with primary fibromyalgia?" Curr Opin Rheumatol 15 (2): 145-50.
- Thieme, K., W. Hauser, et al. (2008). "[Psychotherapy in patients with fibromyalgia syndrome]." Schmerz 22 (3): 295-302.
- Tunks, E., J. Crook, et al. (1988). "Tender points in fibromyalgia." Pain 34 (1): 11-9.
- Turk, D. C., A. Okifuji, et al. (1998). "Differential responses by psychosocial subgroups of fibromyalgia syndrome patients to an interdisciplinary treatment." Arthritis Care Res 11 (5): 397-404.
- Uceyler, N., M. Offenbacher, et al. (2008). "New treatment options for fibromyalgia: critical appraisal of duloxetine." Neuropsychiatr Dis Treat 4 (3): 525-9.
- Vaeroy, H., R. Helle, et al. (1988). "Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis." Pain 32 (1): 21-6.
- Van Houdenhove, B., E. Neerinckx, et al. (2001). "Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: a controlled study on prevalence and characteristics." Psychosomatics 42 (1): 21-8.
- van Santen, M., P. Bolwijn, et al. (2002). "A randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgia." J Rheumatol 29 (3): 575-81.
- Walker, E. A., D. Keegan, et al. (1997). "Psychosocial factors in fibromyalgia compared with rheumatoid arthritis: I. Psychiatric diagnoses and functional disability." Psychosom Med 59 (6): 565-71.
- Weir, P. T., G. A. Harlan, et al. (2006). "The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes." J Clin Rheumatol 12 (3): 124-8.
- Weissbecker, I., A. Floyd, et al. (2006). "Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome." Psychoneuroendocrinology 31 (3): 312-24.
- Wood, P. B., P. Schweinhardt, et al. (2007). "Fibromyalgia patients show an abnormal dopamine response to pain." Eur J Neurosci 25 (12): 3576-82.
- Yunus, M. B., A. T. Masi, et al. (1989). "Preliminary criteria for primary fibromyalgia syndrome (PFS): multivariate analysis of a consecutive series of PFS, other pain patients, and normal subjects." Clin Exp Rheumatol 7 (1): 63-9.
Cited by
Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update
Skelly, A. C., Chou, R., Dettori, J. R., Turner, J. A., Friedly, J. L., Rundell, S. D., Fu, R., Brodt, E. D., Wasson, N., Kantner, S., et al. (2020) · doi:10.23970/ahrqepccer227 · Cited by 256
Mind and body therapy for fibromyalgia
Theadom, A., Cropley, M., Smith, H. E., Feigin, V. L., & McPherson, K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001980.pub3 · Cited by 128
Tosti, B., Corrado, S., Mancone, S., Libero, T. D., Rodio, A., Andrade, A., & Diotaiuti, P. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1358481 · Cited by 102
“…fibromyalgia/chronic fatigue syndrome, repetitive strain injury, tinnitus, arthritis, diabetes, pediatric migraine, anxiety, chronic pain, temporomandibular junction disorders, and adult tension headache (Blume et al., 2012; Šečić et al., 2016; Baumueller et al., 2017; Lazaridou et al., 2023).”
BackgroundHernando-Garijo, I., Jiménez-del-Barrio, S., Mingo-Gómez, T., Medrano-de-la-Fuente, R., & Ceballos-Laita, L. (2022) · Journal of Back and Musculoskeletal Rehabilitation · doi:10.3233/bmr-200282 · Cited by 48
Mind-body therapy for treating fibromyalgia: a systematic review
Steen, J. P., Kannan, V., Zaidi, A., Cramer, H., & Ng, J. Y. (2024) · Pain Medicine · doi:10.1093/pm/pnae076 · Cited by 38
“Second, the evidence for outcomes in this review was limited by the methodological quality of the trials, with only 9 of the 22 included RCTs con - sidered to be of high methodological quality (met ≥ 65% of criteria).”
Influential
Metadata
- Authors
- Baumueller, E., Winkelmann, A., Irnich, D., & Weigl, M.
- Affiliations
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
- Venue
- Complementary Medicine Research
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 24
- Issue
- 1
- Pages
- 33-39
- ISSN
- 1424-7364 (ISSN-L)
- 2504-2092
- 2504-2106
- OpenAlex
- W44719938
- Cited by
- 20
- References
- 35
- Citations by year
- 2025: 3 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 5 · 2019: 3 · 2017: 1
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Complementary Medicine Research (publishedVersion)
- PubMed (publishedVersion)
- Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Myofascial pain diagnosis and treatment
- Health Sciences › Dentistry › Oral Surgery › Temporomandibular Joint Disorders
- Keywords
- fibromyalgia, chronic pain, Fibromyalgia Impact Questionnaire, pressure pain threshold, trapezius, health status, usual care
- MeSH terms
- Female, Fibromyalgia, Humans, Male, Surveys and Questionnaires, Treatment Outcome, Neurofeedback, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Electromyogram Biofeedback in Patients with Fibromyalgia: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1159/000454692
- The paper
- Baumueller, E., Winkelmann, A., Irnich, D., & Weigl, M. (2017). Electromyogram Biofeedback in Patients with Fibromyalgia: A Randomized Controlled Trial. Complementary Medicine Research. https://doi.org/10.1159/000454692
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.